Monthly Archives: February 2020
Registration now open for April 18 Shade Tree Trot
The 12th annual Shade Tree Trot, presented by Messer Construction and Synovus Bank, is set for Saturday, April 18, at 9 a.m. on the Vanderbilt campus. Continue reading
Shon Dwyer, new president of Vanderbilt University Adult Hospital, to meet employees at two town halls March 5
Shon Dwyer, MBA, RN, the new president of Vanderbilt University Adult Hospital (VUAH), will meet employees at two town halls, one in the morning, one in the afternoon, on Thursday, March 5 in Light Hall. Continue reading
“Discover”: The cellular cascade leading to gastric cancers
Arbee Hossain is a genius at helping the Children’s Hospital Outpatient Pharmacy operate best for patients and employees
“He works so hard behind the scenes, then shows up to the patient’s room with a smile on his face and makes the whole process appear seamless and easy.” Continue reading
Health Plus launches Fuel Up Challenge, hosts Nutrition Expo on March 18
Potential new heartburn drug studied at VUMC
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor, a new study suggests. Continue reading
REDcap intermediate training set for March 12
Local honky-tonks may have unsafe noise levels, Vanderbilt researchers report
Noise levels inside downtown Nashville’s “honky-tonk” venues may surpass safe listening levels, a new study by Vanderbilt University Medical Center researchers reports. Researchers found that the average maximum sound level across all venues was approx… Continue reading
5 CREATION OF A CHRONIC PERIANAL CROHN’S FISTULA IN SWINE
Perianal Crohn’s disease (PCD) is associated with worse outcomes including poor quality of life and higher medical costs. PCD is notoriously difficult to treat despite advancements in biologic therapies for luminal disease. In order to test innovative … Continue reading
18 A HUMAN-DERIVED 5-MER PEPTIDE (MTADV), WHICH RESTRICTIVELY ALLEVIATES THE PRO-INFLAMMATORY ACTIVITY OF SERUM AMYLOID A (SAA), SUBSTANTIALLY AMELIORATES IBD PATHOLOGY: NEW POTENTIAL DRUG (MTADV) AND THERAPEUTIC TARGET CANDIDATE (SAA) FOR IBD
A human anti-inflammatory 5-MER peptide MTADV (methionine-threonine-alanine-aspartic acid-valine) derived from a sequence of a pro-inflammatory CD44 variant was first described by us in Nedvetzki et al., J. Clin. Invest. 111,1211-1220, 2003. A NCBI BLA… Continue reading